Urbonaviciene et al. (2011) showed that PAD patients with high serum cystatin C levels had higher all-cause mortality (adjusted HR 2.99) and cardiovascular mortality (adjusted HR 4.36) [35]. The gene discussed is CST3; the disease is peripheral arterial disease.